UK
Science & Innovation Network, India and the Royal Society of Chemistry have
put together a report of interest. The report is titled: “Report on the UK-India
Workshop and Roundtable on Mitigating Anti-microbial Resistance (AMR) and
Controlling Infectious Diseases.”
The
report is based on a meeting between the two bodies.
The
key finding is:
“R&D
in Central Nervous System (CNS) and antimicrobials has decreased significantly
over the last 20 years globally. There is declining interest among Indian and
global pharma companies to undertake research in AMR drug discovery due to the
long gestation period, low returns and lack of expertise. For example, most
drug discovery chemists do not understand the biology of the disease. There are
fewer number of infectious diseases biologists in India.”
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources